JP3480952B2 - External preparation for skin - Google Patents

External preparation for skin

Info

Publication number
JP3480952B2
JP3480952B2 JP21786192A JP21786192A JP3480952B2 JP 3480952 B2 JP3480952 B2 JP 3480952B2 JP 21786192 A JP21786192 A JP 21786192A JP 21786192 A JP21786192 A JP 21786192A JP 3480952 B2 JP3480952 B2 JP 3480952B2
Authority
JP
Japan
Prior art keywords
extract
skin
external preparation
inflammatory
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP21786192A
Other languages
Japanese (ja)
Other versions
JPH0665042A (en
Inventor
昭伸 林
さつき 栗林
紀子 伊田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kose Corp
Original Assignee
Kose Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp filed Critical Kose Corp
Priority to JP21786192A priority Critical patent/JP3480952B2/en
Publication of JPH0665042A publication Critical patent/JPH0665042A/en
Application granted granted Critical
Publication of JP3480952B2 publication Critical patent/JP3480952B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、優れた皮膚炎症防止効
果、美白効果を有する皮膚外用剤に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation having an excellent skin inflammation preventing effect and a whitening effect.

【0002】[0002]

【従来の技術】従来、日焼けによる皮膚の炎症を抑える
ために、カラミン等の抗炎症効果を有する薬剤が、ま
た、日焼け後の色素沈着を抑えるためには、アスコルビ
ン酸、グルタチオン等の美白効果を有する薬剤が皮膚外
用剤の成分として用いられてきた。
2. Description of the Related Art Conventionally, agents having an anti-inflammatory effect such as calamine have been used to suppress skin inflammation due to sunburn, and whitening effects such as ascorbic acid and glutathione have been used to suppress pigmentation after sunburn. The medicines it has been used as a component of external preparations for skin.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、これら
の薬剤を含有する皮膚外用剤は、抗炎症効果、美白効果
が弱く、未だ充分満足すべきものではなかった。
However, external preparations for skin containing these agents have weak anti-inflammatory effects and whitening effects, and have not been sufficiently satisfactory.

【0004】[0004]

【課題を解決するための手段】上記実情に鑑み、本発明
者らは、鋭意研究を行った結果、マイカイカ、モッカ又
はイクリニンの抽出物(以下、バラ科植物抽出物と称す
ることもある)と、特定の抗炎症作用を有する物質を配
合することにより、前記問題点を解決し、日焼けによる
皮膚の炎症及び日焼け後の色素沈着を抑える効果を相乗
的に改善した皮膚外用剤が得られることを見出し、本発
明を完成した。
In view of the above-mentioned circumstances, the inventors of the present invention have conducted diligent research and as a result, have found that an extract of squid, mocca or iclinin (hereinafter, also referred to as an extract of the family Rosaceae) By adding a substance having a specific anti-inflammatory effect, it is possible to obtain a skin external preparation which solves the above problems and synergistically improves the effects of suppressing skin inflammation due to sunburn and pigmentation after sunburn. Heading, completed the present invention.

【0005】すなわち、本発明は、 (A1)マイカイカ抽出物、及び (B1)(イ)トウキンセンカ抽出物、又は(ロ)グア
イアズレン、ε−アミノカプロン酸若しくはこれらの誘
導体の1種又は2種以上を含有することを特徴とする抗
炎症及び美白用皮膚外用剤; (A2)モッカ抽出物、及び (B2)ニワトコ抽出物を含有することを特徴とする抗
炎症及び美白用皮膚外用剤; (A3)イクリニン抽出物、及び (B3)ガマ抽出物を含有することを特徴とする抗炎症
及び美白用皮膚外用剤を提供するものである。
That is, the present invention relates to (A 1 ) mica squid extract, and (B 1 ) (i) Scutellaria barba extract, or (b) guaiazulene, ε-aminocaproic acid, or one or two of these derivatives. Anti-inflammatory and whitening skin external preparation containing the above; (A 2 ) Mokka extract and (B 2 ) elderberry extract containing anti-inflammatory and whitening skin external preparation ; (a 3) Ikurinin extract, and (B 3) is intended to provide an anti-inflammatory and whitening skin external agent characterized by containing cattail extract.

【0006】本発明の(A)成分のバラ科植物抽出物の
調製法は特に限定されないが、例えば種々の適当な溶媒
を用いて室温〜加温下で抽出される。抽出溶媒として
は、例えば水;メチルアルコール、エチルアルコール等
の低級一価アルコール;グリセリン、プロピレングリコ
ール、1,3−ブチレングリコール等の液状多価アルコ
ール;酢酸エチル等の低級アルキルエステル;ベンゼ
ン、ヘキサン等の炭化水素;ジエチルエーテル等のエー
テル類等の1種又は2種以上を用いることができる。特
に水、エチルアルコール、グリセリン、1,3−ブチレ
ングリコールの1種又は2種以上の混合溶媒が好まし
い。また抽出条件としては、バラ科植物に対し容量比で
1〜1000倍量、特に5〜100倍量の溶媒を用い、
4℃以上、特に15〜30℃の温度で1時間以上、特に
1〜3日間行うのが好ましい。
The method of preparing the extract of the plant of the family Rosaceae of the component (A) of the present invention is not particularly limited, but it is extracted, for example, using various suitable solvents at room temperature to under heating. Examples of the extraction solvent include water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol; lower alkyl esters such as ethyl acetate; benzene and hexane. Hydrocarbons; one kind or two or more kinds of ethers such as diethyl ether can be used. Particularly, water, ethyl alcohol, glycerin, and a mixed solvent of one or more kinds of 1,3-butylene glycol are preferable. As the extraction conditions, a solvent is used in a volume ratio of 1 to 1000 times, particularly 5 to 100 times the volume of the Rosaceae plant,
It is preferable to carry out at a temperature of 4 ° C. or higher, particularly 15 to 30 ° C., for 1 hour or longer, particularly 1 to 3 days.

【0007】以上のような条件で得られるバラ科植物抽
出物は、抽出された溶液のまま用いても良いが、更に必
要により濃縮、ろ過等の処理をしたものを用いることが
できる。また、これらは単独でも、2種以上を組合せて
使用することもできる。
The Rosaceae plant extract obtained under the above conditions may be used as it is as an extracted solution, but if necessary, it may be subjected to treatments such as concentration and filtration. These may be used alone or in combination of two or more.

【0008】本発明の皮膚外用剤において、(A)成分
の配合量は、乾燥固形分に換算して0.0001〜1
0.0重量%(以下、単に「%」で示す)が好ましく、
特に0.01〜5.0%の範囲が好ましい。含有量が
0.0001%未満であると効果が充分発揮されず、1
0.0%を超えても、それ以上の効果の増大は見られな
い。
In the external preparation for skin of the present invention, the compounding amount of the component (A) is 0.0001 to 1 in terms of dry solid content.
0.0 wt% (hereinafter referred to simply as "%") is preferable,
Particularly, the range of 0.01 to 5.0% is preferable. If the content is less than 0.0001%, the effect is not sufficiently exerted and 1
Even if it exceeds 0.0%, the effect is not further increased.

【0009】また、本発明の皮膚外用剤の(B)成分の
(イ)の抗炎症作用をもつ植物抽出物は、トウキンセン
カ、ニワトコ又はガマを、水、エタノール、プロピレン
グリコール、1,3−ブチレングリコール等の1種又は
2種以上の溶媒で抽出したもの、又はこの抽出物を乾燥
したものである。
The plant extract having an anti-inflammatory effect of the component (B) of the external preparation for skin of the present invention, which has anti-inflammatory action, is the same as that of Scutellaria barbata L., elder or cattail, and water, ethanol, propylene glycol, 1,3-. It is obtained by extracting with one or more solvents such as butylene glycol, or by drying this extract.

【0010】この植物抽出成分の配合量は、乾燥重量と
して本発明皮膚外用剤全量中0.0001〜10%、特
に0.01〜5%が好ましい。
The blending amount of the plant extract component is preferably 0.0001 to 10%, and particularly preferably 0.01 to 5% as a dry weight in the total amount of the skin external preparation of the present invention.

【0011】[0011]

【0012】(B)成分の(ロ)のグアイアズレン又は
その誘導体としてはグアイアズレン、グアイアズレンス
ルホン酸、その塩、そのエステル等が挙げられ、具体的
にはグアイアズレン、グアイアズレンスルホン酸エチ
ル、グアイアズレンスルホン酸ナトリウムなどが例示さ
れる。配合量は、皮膚外用剤全量中の0.001〜8
%、特に0.1〜5%が好ましい。
Examples of the component (B) (B) guaiazulene or its derivative include guaiazulene, guaiazulene sulfonic acid, salts thereof and esters thereof. Specific examples thereof include guaiazulene, ethyl guaiazulene sulfonate and sodium guaiazulene sulfonate. Is exemplified. The compounding amount is 0.001 to 8 in the total amount of the external preparation for skin.
%, Particularly 0.1-5% is preferable.

【0013】ε−アミノカプロン酸の配合量は、皮膚外
用剤全量中の0.001〜8%、特に0.1〜5%が好
ましい。
The content of ε-aminocaproic acid is preferably 0.001 to 8%, more preferably 0.1 to 5% of the total amount of the external preparation for skin.

【0014】更に、本発明の皮膚外用剤には、本発明の
効果を損なわない範囲で、前記必須成分の他、通常の皮
膚外用剤に用いられる水性成分、粉体、界面活性剤、油
剤、保湿剤、アルコール類、pH調整剤、防腐剤、色素、
酸化防止剤、紫外線吸収剤、増粘剤、香料、美容成分等
を必要に応じて適宜配合することができる。
Further, the external preparation for skin of the present invention contains, in addition to the above-mentioned essential components, aqueous components, powders, surfactants, oils, which are used in ordinary external preparations for skin, as long as the effects of the present invention are not impaired. Moisturizers, alcohols, pH adjusters, preservatives, pigments,
Antioxidants, ultraviolet absorbers, thickeners, fragrances, beauty ingredients and the like can be appropriately added as needed.

【0015】本発明の皮膚外用剤は、必須成分である
(A)及び(B)成分を配合し、常法に従って製造する
ことができる。そして乳液、クリーム、化粧水、美容
液、クレンジング、パック、ファンデーション、洗浄料
等の他、分散状、軟膏状、顆粒状等の医薬用、医薬部外
用又は化粧用の製剤とすることができる。
The external preparation for skin of the present invention can be produced by mixing the essential components (A) and (B) in a conventional manner. In addition to emulsions, creams, lotions, beauty essences, cleansing, packs, foundations, detergents, etc., it can be made into pharmaceuticals such as dispersions, ointments and granules, quasi-drugs or cosmetics.

【0016】[0016]

【実施例】次に試験例及び実施例を挙げて本発明を更に
詳細に説明するが、本発明はこれらに限定されるもので
はない。
EXAMPLES The present invention will be described in more detail with reference to test examples and examples, but the present invention is not limited thereto.

【0017】尚、マイカイカ抽出物、モッカ抽出物及び
イクリニン抽出物としては次のものを使用した。 マイカイカ抽出物:30v/v%エチルアルコールにて
加熱抽出後、ろ過し、減圧濃縮したものを冷所に放置し
て熟成させたもの。乾燥固形分約3%。 モッカ抽出物:50v/v%エチルアルコールにて還流
抽出後、ろ過し、減圧濃縮したものを冷所に放置したも
の。乾燥固形分約2%。 イクリニン抽出物:50v/v%エチルアルコールを加
え、時々振とうしながら室温で3日間抽出後、ろ過し、
減圧濃縮したもの。乾燥固形分約6%。
The followings were used as the mica extract, mocca extract and iclinin extract. Maika squid extract: Heat-extracted with 30 v / v% ethyl alcohol, filtered, concentrated under reduced pressure, and allowed to stand in a cool place for aging. About 3% dry solids. Mocca extract: Extracted by refluxing with 50 v / v% ethyl alcohol, filtered, concentrated under reduced pressure, and allowed to stand in a cool place. About 2% dry solids. Iclinin extract: 50v / v% ethyl alcohol was added, and the mixture was extracted for 3 days at room temperature with occasional shaking, and then filtered,
Concentrated under reduced pressure. About 6% dry solids.

【0018】実施例1 表1に示した薬剤及びエタノールを15重量%含み、残
部が精製水からなる化粧水を調製し、有色モルモット背
部に塗布してその日焼けによる炎症、色素沈着に対する
効果を調べた。
Example 1 A lotion containing 15% by weight of the drug shown in Table 1 and ethanol and the remainder being purified water was prepared and applied to the back of a colored guinea pig to examine its effect on inflammation and pigmentation due to sunburn. It was

【0019】(試験方法)有色モルモット(各群10
匹)の背部を剃毛し、麻酔下紫外線を照射した。紫外線
照射は、東芝(株)製FL20S・BLBランプとFL
20S・E30ランプを3本ずつ同時に照射し、紫外線
量は、4.8×106erg/cm2 とした。紫外線照射24
時間前と照射直後及び照射12時間後、24時間後にモ
ルモット背部の4箇所に試料を0.2mlずつよくすりこ
んだ。但し、照射前には塗布部位を温水で良く洗浄し
た。照射の24時間後に炎症の程度を観察し、7日後
に、色素沈着の程度を観察し、以下の判定基準で判定し
た。
(Test method) Colored guinea pigs (10 for each group)
The back of each animal was shaved and irradiated with ultraviolet rays under anesthesia. Ultraviolet irradiation is performed by Toshiba Corporation FL20S / BLB lamp and FL
Three 20S / E30 lamps were simultaneously irradiated, and the amount of ultraviolet rays was 4.8 × 10 6 erg / cm 2 . UV irradiation 24
0.2 ml each of the sample was rubbed well at four points on the back of the guinea pig before and immediately after the irradiation, and 12 hours and 24 hours after the irradiation. However, the application site was thoroughly washed with warm water before irradiation. The degree of inflammation was observed 24 hours after the irradiation, and after 7 days, the degree of pigmentation was observed and judged according to the following criteria.

【0020】(判定基準) 炎症についての判定基準(抗炎症効果) 0:炎症がまったく認められない。 1:ごく僅か炎症が認められる。 2:炎症が認められるが、非照射部位との境界は不明
瞭。 3:炎症が認められ、非照射部位との境界は鮮明。 色素沈着についての判定基準(美白効果) 0:色素沈着がまったく認められない。 1:ごく僅か色素沈着が認められる。 2:色素沈着が認められるが、非照射部位との境界は不
明瞭。 3:色素沈着が認められ、非照射部位との境界は鮮明。
(Criteria) Criteria for inflammation (anti-inflammatory effect) 0: No inflammation is observed at all. 1: Very slight inflammation is observed. 2: Inflammation is observed, but the boundary with the non-irradiated site is unclear. 3: Inflammation was observed and the boundary with the non-irradiated site was clear. Criteria for pigmentation (whitening effect) 0: No pigmentation is observed. 1: Very slight pigmentation is observed. 2: Pigmentation is observed, but the boundary with the non-irradiated site is unclear. 3: Pigmentation was observed, and the boundary with the non-irradiated site was clear.

【0021】[0021]

【表1】 [Table 1]

【0022】(判定)それぞれの評点が1点以下のモル
モットが10匹中 8匹以上:著効 6匹以上:有効 4匹以上:やや有効 3匹以下:無効 結果を表2に示す。
(Judgment) 8 or more out of 10 guinea pigs each having a score of 1 or less: excellent effect 6 or more: effective 4 or more: moderately effective 3 or less: invalid results are shown in Table 2.

【0023】[0023]

【表2】 [Table 2]

【0024】実施例2 実施例1と同様にして表3に示す薬剤の日焼けによる炎
症、色素沈着に対する効果を調べた。その結果を表4に
示す。
Example 2 In the same manner as in Example 1, the effects of the agents shown in Table 3 on inflammation and pigmentation due to sunburn were examined. The results are shown in Table 4.

【0025】[0025]

【表1】 [Table 1]

【0026】[0026]

【表2】 [Table 2]

【0027】表2及び表4の結果から、(A)及び
(B)成分を配合した本発明の化粧水は、それぞれを単
独で含む化粧水に比べて抗炎症効果及び美白効果が優れ
ていることがわかる。
From the results shown in Tables 2 and 4, the lotion of the present invention containing the components (A) and (B) is superior in anti-inflammatory effect and whitening effect as compared with the lotion containing each of them alone. I understand.

【0028】[0028]

【0029】[0029]

【0030】[0030]

【0031】[0031]

【0032】[0032]

【0033】[0033]

【0034】[0034]

【発明の効果】以上詳述した如く、本発明の皮膚外用剤
は日焼けによる皮膚の炎症及び日焼け後の色素沈着の抑
制効果に優れたものである。
INDUSTRIAL APPLICABILITY As described above in detail, the external preparation for skin of the present invention is excellent in the effect of suppressing skin inflammation due to sunburn and pigmentation after sunburn.

フロントページの続き (51)Int.Cl.7 識別記号 FI A61K 35/78 A61K 35/78 C (72)発明者 伊田 紀子 東京都北区栄町48番18号 株式会社コー セー研究所内 (56)参考文献 特開 平3−236322(JP,A) 特開 平3−236323(JP,A) 特開 昭62−298508(JP,A) 特開 平3−127714(JP,A) 特開 平3−188008(JP,A) 特開 平3−188013(JP,A) 特開 平3−188014(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 A61K 7/48 A61K 35/78 Continuation of the front page (51) Int.Cl. 7 Identification code FI A61K 35/78 A61K 35/78 C (72) Inventor Noriko Ida 48-18 Sakaemachi, Kita-ku, Tokyo (56) Reference Documents JP-A-3-236322 (JP, A) JP-A-3-236323 (JP, A) JP-A-62-298508 (JP, A) JP-A-3-127714 (JP, A) JP-A-3- 188008 (JP, A) JP-A-3-188013 (JP, A) JP-A-3-188014 (JP, A) (58) Fields investigated (Int.Cl. 7 , DB name) A61K 7/00 A61K 7 / 48 A61K 35/78

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 (A1)マイカイカ抽出物、及び (B1)(イ)トウキンセンカ抽出物、又は(ロ)グア
イアズレン、ε−アミノカプロン酸若しくはこれらの誘
導体の1種又は2種以上を含有することを特徴とする抗
炎症及び美白用皮膚外用剤。
1. An (A 1 ) mica extract, and (B 1 ) (a) Scutellaria barba extract, or (b) guaiazulene, ε-aminocaproic acid, or one or more of these derivatives. An anti-inflammatory and whitening skin external preparation characterized by the following:
【請求項2】 (A2)モッカ抽出物、及び (B2)ニワトコ抽出物を含有することを特徴とする抗
炎症及び美白用皮膚外用剤。
2. An external anti-inflammatory and whitening skin preparation, which comprises (A 2 ) mocca extract and (B 2 ) elder extract.
【請求項3】 (A3)イクリニン抽出物、及び (B3)ガマ抽出物を含有することを特徴とする抗炎症
及び美白用皮膚外用剤。
Wherein (A 3) Ikurinin extract, and (B 3) anti-inflammatory and whitening skin external agent characterized by containing cattail extract.
JP21786192A 1992-08-17 1992-08-17 External preparation for skin Expired - Lifetime JP3480952B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21786192A JP3480952B2 (en) 1992-08-17 1992-08-17 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21786192A JP3480952B2 (en) 1992-08-17 1992-08-17 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH0665042A JPH0665042A (en) 1994-03-08
JP3480952B2 true JP3480952B2 (en) 2003-12-22

Family

ID=16710918

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21786192A Expired - Lifetime JP3480952B2 (en) 1992-08-17 1992-08-17 External preparation for skin

Country Status (1)

Country Link
JP (1) JP3480952B2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0977636A (en) * 1995-09-14 1997-03-25 Mikimoto Pharmaceut Co Ltd Beautifying and whitening cosmetic
JPH09157151A (en) * 1995-12-05 1997-06-17 Noevir Co Ltd Melanin generation inhibitor and whitening agent
FR2754447B1 (en) * 1996-10-16 1999-07-23 Codif International Sa COSMETIC COMPOSITION FOR PROTECTING SKIN FROM THE SUN AND PROCESS FOR PRODUCING THE SAME
FR2768622B1 (en) * 1997-09-22 1999-11-26 Oreal Rosacea extract as antagonist of bradykinin
FR2768621B1 (en) * 1997-09-22 2000-04-07 Oreal USE OF AN EXTRACT OF AT LEAST ONE PLANT FROM THE ROSACEA FAMILY
JP2001064192A (en) * 1999-08-25 2001-03-13 Sunstar Inc Migration inhibitor for langerhans cell and antigen presentation inhibitor
DE10353607A1 (en) * 2003-11-17 2005-06-16 Beiersdorf Ag Jelaengerjelieber (especially Lonicera japonica (Japanese honeysuckle)) flower extract is used in after-shave compositions to treat shaving-induced skin and connective tissue damage
US20090317341A1 (en) 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
KR100981523B1 (en) * 2009-03-10 2010-09-10 김관철 Cosmetic composition for treatment acne
JP2018070450A (en) * 2016-10-24 2018-05-10 オッペン化粧品株式会社 Plasmin inhibitor
CN114129485B (en) * 2021-12-21 2023-10-10 南京华开生物科技有限公司 Moisturizing amino acid facial cleanser and preparation process thereof
CN114432222B (en) * 2022-01-24 2023-07-21 西安拜尔海森生物制药有限公司 Water aqua for oral care and preparation method thereof
CN115413684B (en) * 2022-09-22 2023-10-13 烟台固特丽生物科技股份有限公司 Homopteran insect repellent prepared from typha extract

Also Published As

Publication number Publication date
JPH0665042A (en) 1994-03-08

Similar Documents

Publication Publication Date Title
JP3480952B2 (en) External preparation for skin
JP2929304B2 (en) Skin whitening preparation for external use
JP3415200B2 (en) External preparation for skin
JP3170070B2 (en) External preparation for skin
JP3274506B2 (en) External preparation for skin
JPH108049A (en) Antioxidant composition
JPH08283143A (en) Skin preparation for external use
JPH06336421A (en) External agent for skin
JPH11349435A (en) Skin agent used for external use and effective for preventing and improving pigmentary symptom caused by ultraviolet light
JP3480954B2 (en) External preparation for skin
JPH06271452A (en) Skin cosmetic containing extract of plant of cactuses
JP2501593B2 (en) Topical agent for suppressing melanin production
JP2891727B2 (en) Hair restoration
JP3359774B2 (en) External preparation for skin
JPH0643293B2 (en) External skin preparation
JP2855274B2 (en) Hair restoration
JPS62234006A (en) External drug for skin
JPH049315A (en) Whitening cosmetic
JP3150845B2 (en) UV absorbers and UV protection cosmetics containing the same
JPH1046142A (en) Antioxidant
JP3563947B2 (en) External preparation for skin
JP2811479B2 (en) Hair restoration
JPH1046143A (en) Antioxidant
JPH0543447A (en) Skin medicine for external use
JP2999621B2 (en) External preparation for skin

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091010

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121010

Year of fee payment: 9

EXPY Cancellation because of completion of term